Karus Therapeutics

Biotechnology, Life Science, Pharmaceutical
Founded in 2005-01-01
Chilworth, Hampshire, United Kingdom
For Profit

About Karus Therapeutics

Karus is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 11 active products

Financial Information

  • Estimated Revenue: $10M to $50M
  • Total Funding: 14753207 USD
  • Last Funding: None (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Karus Therapeutics actively uses 11 products in their tech stack.

Market Presence

Industries: Biotechnology, Life Science, Pharmaceutical

Headquarters: Chilworth, Hampshire, United Kingdom